They may advise against these medications if you have a personal or family history of certain conditions like medullary thyroid cancer or MEN 2
Novel dual incretin agent, tirzepatide (LY3298176), for the treatment of type 2 diabetes mellitus and cardiometabolic health
For a long time, they were thought to be absent in biological systems due to their high reactivity and short lifespans
Semaglutide and tirzepatide slow stomach emptying as part of their weight loss mechanism
Our blog is designed to break down treatments, trends, and common questions in a way that makes sense
GLP-1 Microdosing Chart & Schedule According to a 2,700-person real-world study presented at the 2025 European Congress on Obesity, participants achieved an average 16% weight loss over 64 weeks at microdose levels of semaglutide: Microdosing GLP-1 Weight Loss Results Microdose GLP-1 yields 5-10% body weight loss in year one versus 15-20% with full-dose treatment plans